Induction of interleukin-18 in atherosclerotic patients: A role for Chlamydia pneumoniae

Medical Principles and Practice

Volumn 18, Issue 2, 2009, Pages 105-110

  Mousa, Alyaa ^a   Al Zaki, Amani ^b   Taha, Safa ^b   Bakhiet, Moiz ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Atheroma; Bacteria; Cytokine; Inflammation; mRNA

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL RNA; BACTERIUM LIPOPOLYSACCHARIDE; HEAT SHOCK PROTEIN 60; INTERLEUKIN 18; MESSENGER RNA;

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHAPERONIN 60; CHLAMYDOPHILA PNEUMONIAE; DIABETES COMPLICATIONS; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-18; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 60149112541     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189807     Document Type: Article

References (24)

1. Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-372.
2. Mahmoudi M, Curzen N, Gallagher PJ: Atherogenesis: the role of inflammation and infection. Histopathology 2007;50:535-546.
3. Severs NJ, Robenek H: Constituents of the arterial wall and atherosclerotic plaque: an introduction to atherosclerosis; in Robenek H, Severs NJ (eds): Cell Interactions in Atherosclerosis. Boca Raton, CRC Press, 1992.
4. Berger A: Th1 and Th2 responses: what are they? BMJ 2000;12:424.
5. Jawień J: New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 2008;118:127-131.
6. Dinarello CA: Interleukin-18 and the pathogenesis of inflammatory diseases. Semin Nephrol 2007;27:98-114.
7. Hulthe J, McPheat W, Samnegård A, Tornvall P, Hamsten A, Eriksson P: Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 2007;188:450-454.
8. Jha HC, Vardhan H, Gupta R, Varma R, Prasad J, Mittal A: Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern. BMC Infect Dis 2007;7:48.
9. Peeling RW, Brunham RC: Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996;2:307-319.
10. Ward AA: The immunobiology and immunopathology of chlamydial infections. APMIS 1995;103:769-796.
11. Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 2002;288:2724-2731.
12. Boman J, Gaydos CA: Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 2000;181(suppl 3):S452-S454.
13. Moazed TC, Kuo C, Grayston JT, Campbell LA: Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-890.
14. Kalayoglu MV, Byrne GI: Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 1998;177:725-729.
15. Kalayoglu MV, Byrne GI: A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 1998;66:5067-5072.
16. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI: Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae . J Infect Dis 1999;180:780-790.
17. Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI: Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis 2000;181(suppl 3):5483-5489.
18. Bakhiet M, Yu LY, Özenci V, Khan A, Shi FD: Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen. Clin Exp Immunol 2006;144:290-298.
19. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
20. Dinarello CA, Fantuzzi G: Interleukin-18 and host defense against infection. J Infect Dis 2003;15(suppl 2):S370-S384.
21. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H: The role of IFN-gamma in the outcome of chlamydial infection. Curr Opin Immunol 2002;14:444-451.
22. Whitman SC, Ravisankar P, Daugherty A: Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-) mice through release of interferon-gamma. Circ Res 2002;90:E34-E38.
23. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-1603.
24. Danesh J, Collins R, Peto R: Chronic infections and coronary artery disease: is there a link? Lancet 1997;350:430-436.